ׯÏйÙÍø

EN
EN
  • ÒµÎñ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÒµÎñ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
ÁÙ´²Ç°Ñо¿
Preclinical study
ÁÙ´²Ç°Ñо¿

PDXÄ£ÐÍ

PDXÄ£ÐÍ(ÈËÔ´Ö×ÁöÒìÖÖÒÆֲģÐÍ)¿ÉÒÔ½¨Á¢ÀíÏëµÄÖ×ÁöÃâÒßÁÆ·¨ÆÀ¼ÛÄ£ÐÍ¡£×¯ÏйÙÍøµÄPDXÄ£ÐÍÑо¿°üÀ¨·Ö×ÓˮƽµÄ»ùÒò·ÖÐÍÒÔ¼°Ö×ÁöÄ£Ð͵ÄÒ©ÀíҩЧÆÀ¼ÛЧÀÍ £¬ÎªÑо¿ÁÙ´²Ò©Ð§ÌṩÁ˸߶ÈÔ¤²âÐÔµÄÄ£ÐÍ¡£ 

DownloadÎĵµÏÂÔØ
ׯÏйÙÍø×÷ΪһվʽÉúÎïÒ½Ò©ÁÙ´²Ç°Ñз¢Ð§ÀÍƽ̨ £¬¶þÊ®ÄêÀ´²»¾øÉî¸ûÓëÁ¢Òì £¬ÒÑÔÚÖ×ÁöÒ©ÎïÑз¢ÁìÓò¹¹½¨ÆðÒ»Ì×È«Ãæ¶øÏȽøµÄҩЧÆÀ¼ÛÌåϵ £¬º­¸ÇÁ˳¬410ÖÖÖ×ÁöҩЧÆÀ¼ÛÄ£ÐÍ £¬°üÀ¨118ÖÖPDXԭλģÐÍ¡£
ׯÏйÙÍøPDXԭλģÐÍÖÖÀà
  • ׯÏйÙÍø118ÖÖPDXԭλģÐ͹㷺ÁýÕÖÁË´Ó³£¼ûµ½Ï¡ÓеĶàÖÖÖ×ÁöÀàÐÍ £¬ÎªÖ×ÁöÉúÎïѧÑо¿ºÍÒ©ÎïɸѡÌṩÁ˶àÑù»¯µÄÑ¡Ôñ £¬¾ßÌåÄ£ÐÍÈçÏ£º
    °©Ö¢ÀàÐÍPDXÄ£ÐͱàºÅ
    ÄÔ°©551Br
    ÈéÏÙ°©201B, 203B
    ¹¬¾±°©371Ce
    ½á³¦°©002C, 008C, 011C,  013C, 015C, 016C, 020C, 021C, 057C, 058C, 059C, 060C, 061C, 062C, 064C, 065C, 069C,  070C, 072C, 075C, 076C, 084C, 087C, 088C, 095C, 102C, 104C, 110C, 116C, 117C, 128C, 143C, 163C
    ×Ó¹¬ÄÚĤ°©361En
    ʳµÀ°©165Es, 166Es, 341Es
    θ°©091Ga, 092Ga, 122Ga, 126Ga, 142Ga, 145Ga, 254Ga, 256Ga, 258Ga, 147Ga, 153Ga, 152Ga, 151Ga, 156Ga, 154Ga, 150Ga, 155Ga, 157Ga, 158Ga, 159Ga
    Í·¾±°©281T, 285HN, 284HN, 286HN
    ¸Î°©212Li, 213Li, 214Li, 216Li, 217Li
    ·Î°©028Lu, 047Lu, 050Lu, 053Lu, 054Lu, 168Lu, 171Lu, 263Lu, 264Lu, 265Lu, 267Lu, 269Lu
    ÐþÉ«ËØÁö571Me
    Âѳ²°©271O, 272O, 273O, 274O
    ÒÈÏÙ°©167Pa, 221Pa, 222Pa, 223Pa, 224Pa, 225Pa, 226Pa, 228Pa
    Ç°ÁÐÏÙ°©351Pr, 353Pr, 354Pr, 355Pr, 226Pa, 228Pa
    Éö°©301R, 303R, 304R
    ÈâÁö332Sa, 333Sa, 334Sa
    °òë×°©232U, 234U, 235U, 236U, 237U
    °×Ѫ²¡291Le, 292Le, 293Le, 294Le, 295Le
    ÁÜ°ÍÁö244Ly, 245Ly
    ¹ÇËèÁö321MM
  • PDXÄ£ÐÍ(ÈËÔ´Ö×ÁöÒìÖÖÒÆֲģÐÍ)
    SNI:Neuro-Oncology 2015, Vol 6, Suppl I - A supplement to Surgical Neurology International

    SNI:Neuro-Oncology 2015, Vol 6, Suppl I - A supplement to Surgical Neurology International

    PDX Model (Growth Curve)

    PDX Model (Growth Curve)

    PDX Model (MED-PDX-001C H&E (10X))

    PDX Model (MED-PDX-001C H&E (10X))

  • ÏȽøµÄ¼ì²âÑо¿¼¼Êõ°ü¹Ü
    ׯÏйÙÍø½ÓÄÉÁËһϵÁÐÏȽøµÄ»îÌå³ÉÏñ¡¢B³¬µÈ¼¼ÊõÀ´°ü¹ÜPDXÄ£Ð͵ľ«×¼ÐÔÓë¿É¿¿ÐÔ £¬°üÀ¨£º
    1. »îÌå³ÉÏñ¼¼Êõ
    £¨1£©PET/CT·Ö×ÓÓ°Ïñ¼¼Êõ £¬Ö÷ÒªÓÃÓÚÆÀ¹ÀÖ×ÁöÄ£Ð͵Ľ¨Á¢¡¢Ö×ÁöÄ£Ð͵Äɸѡ¡¢Ö×Áö¼ì²â¼°Ò©Ð§ÆÀ¼Û£»
    £¨2£©¿É¼û¹â³ÉÏñ¼¼Êõ £¬ÈçÓ«¹â±ê¼Ç³ÉÏñºÍÉúÎï·¢¹â»îÌå³ÉÏñ¼¼Êõ £¬ÊµÏÖÁ˶ÔÖ×ÁöÉú³¤µÄ·ÇÇÖÈëÐÔʵʱ¼à²â¡£
    2. B³¬¼¼Êõ
    ÀûÓó¬Éù¶àÆÕÀպͳ¬Éù»Ø²¨Ô­Àí £¬¿ÉÒÔÏÔʾ³ö¾Ö²¿ÓÐʵÖÊÐÔµÄÖ×Áö £¬ÌرðÊÊÓÃÓÚÉöÔà¡¢ÒÈÏÙ¡¢Âѳ²¡¢°òë׵Ȳ¿Î»µÄԭλÖ×ÁöÄ£Ðͼà²â¡£
²¿·ÖׯÏйÙÍøPDXԭλģÐÍչʾ
  • 1. ԭλ¸Î°© PDXM-212Li
    ¶¯Î´ÆÐÔÂãÊó
    PDX£ºPDXM-212Li
    ×éÖ¯ÀàÐÍ£º¸ÎÔà
    Ä£Ðͽ¨Á¢£ºÔ­Î»Ö²ÈëÖ×Áö×éÖ¯¿é
    ³ÉÏñ£º³¬Éù£¨L38-22 £¬30MHz£©
    1 ԭλ¸Î°© PDXM-212Li -1.jpg
    1 ԭλ¸Î°© PDXM-212Li -2.jpg
  • 2. ԭλÒÈÏÙ°© PDXM-222Pa
    ¶¯Î´ÆÐÔÂãÊó
    PDX£ºPDXM-222Pa
    ×éÖ¯ÀàÐÍ£ºÒÈÏÙ
    Ä£Ðͽ¨Á¢£ºÔ­Î»Ö²ÈëÖ×Áö×éÖ¯¿é
    ³ÉÏñ£º³¬Éù£¨L38-22 £¬30MHz£©
    2 ԭλÒÈÏÙ°© PDXM-222Pa.jpg
  • 3. ԭλÂѳ²°© PDXM-271O
    ¶¯Î´ÆÐÔÂãÊó
    PDX£ºPDXM-271O
    ×éÖ¯ÀàÐÍ£ºÂѳ²
    Ä£Ðͽ¨Á¢£ºÔ­Î»Ö²ÈëÖ×Áö×éÖ¯¿é
    ³ÉÏñ£º³¬Éù£¨L38-22 £¬30MHz£©
    3 ԭλÂѳ²°© PDXM-271O -1.jpg
    3 ԭλÂѳ²°© PDXM-271O -2.jpg
  • 4. ԭλ°òë×°© PDXM-237U
    ¶¯Î´ÆÐÔÂãÊó
    PDX£ºPDXM-237U
    ×éÖ¯ÀàÐÍ£º°òë×
    Ä£Ðͽ¨Á¢£ºÔ­Î»Ö²ÈëÖ×Áö×éÖ¯¿é
    ³ÉÏñ£º³¬Éù£¨L38-22 £¬30MHz£©
    4 ԭλ°òë×°© PDXM-237U.jpg
  • 5. ԭλÉö°© PDXM-303R
    ¶¯Î´ÆÐÔÂãÊó
    PDX£ºPDXM-303R
    ×éÖ¯ÀàÐÍ£ºÉöÔà
    Ä£Ðͽ¨Á¢£ºÔ­Î»Ö²ÈëÖ×Áö×éÖ¯¿é
    ³ÉÏñ£º³¬Éù£¨L38-22 £¬30MHz£©
    5 ԭλÉö°© PDXM-303R.jpg
"PDXÄ£ÐÍ"Ïà¹ØÊÓƵÍƼö
  • ʲôÊÇÁÙ´²Ç°Ñо¿µÄPDXÄ£ÐÍ £¿

    ÈçºÎÓÃPDXÄ£ÐÍ¿ªÆô¸öÐÔ»¯µÄ¾«×¼Ò©Ð§ÆÀ¼Û £¿

"PDXÄ£ÐÍ"Ïà¹ØÎÄÕÂÍƼö
FAQs
  • ʲôÊÇPDXÄ£ÐÍ £¿

    PDX(Patient-Derived Tumor Xenograft)Ä£ÐÍÊǽ«À´Ô´ÓÚ»¼ÕßÖ×ÁöµÄ×éÖ¯¿éÖ±½ÓÒÆÖ²µ½ÃâÒßȱÏÝÐÍÊóÉÏ£¨ÈçÉö°üĤÏ¡¢Æ¤Ï»òԭ룩¶ø½¨Á¢µÄÈËÔ´ÒìÖÖÒÆֲģÐÍ¡£

  • PDXÄ£Ð͵Ľ¹µãÓÅÊÆ

    1. ±£È«Ö×ÁöÔ­ÓÐÌØÐÔºÍÒìÖÊÐÔ£º
    PDXÄ£ÐÍͨ¹ýÖ±½Ó½«»¼ÕßÖ×Áö×éÖ¯¿éÒÆÖ²µ½ÃâÒßȱÏÝÊóÉÏ £¬ÖÆÖ¹ÁËÌåÍâÅàÑøÀú³ÌÖжÔÖ×Áöϸ°ûµÄɸѡ £¬´Ó¶øÈ«Ã汣ȫÁËÖ×ÁöÔ­ÓеÄÉúÎïѧÌØÐÔ¼°ÆäÄÚÔÚµÄÒìÖÊÐÔ¡£

    2. ¼á³Ö·Ö×ÓÉúÎïˮƽµÄÎȶ¨ÐÔ£º
    ÔÚ´«´úÀú³ÌÖÐ £¬PDXÄ£ÐÍÄܹ»¼á³Ö·Ö×ÓÉúÎïѧˮƽµÄÎȶ¨ £¬È·±£Ö×Áöϸ°ûµÄÒÅ´«ÐÅÏ¢ºÍ±í´ïģʽ»ñµÃºÜºÃµÄͨ±¨ £¬Îªºã¾ÃÊÓ²ìºÍÒ©ÎïɸѡµÓÚ¨¼áʵ»ù´¡¡£

    3. ±£´æÖ×Áö×éÖ¯Ô­ÓеķÇÖ×Áö»ùÖʺÍ΢Çé¿ö£º
    ³ýÁËÖ×Áöϸ°ûÍâ £¬PDXÄ£ÐÍ»¹±£´æÁËÖ×Áö×éÖ¯Ô­ÓеķÇÖ×Áö»ùÖʺÍ΢Çé¿ö £¬Õâ¹ØÓÚÀí½âÖ×ÁöÓëËÞÖ÷¼äµÄÏ໥×÷Óá¢Ö×ÁöÉú³¤ÓëתÒÆ»úÖÆÖÁ¹ØÖØÒª¡£

    4. °ü¹Ü¸ß¶ÈµÄÁÙ´²Ïà¹ØÐÔ£º
    ÓÉÓÚPDXÄ£ÐÍÔÚ¶à¸ö·½Ãæ¸ß¶ÈÄ£ÄâÁËÁÙ´²²¡ÈËÖ×ÁöµÄÌØÕ÷ £¬Òò´ËÆäÑо¿½á¹û¾ßÓиü¸ßµÄÁÙ´²×ª»¯Ç±Á¦ £¬ÎªÖ×ÁöÖÎÁƼƻ®µÄÖƶ¨ÌṩÁËÔ½·¢¿É¿¿µÄ¿ÆѧÒÀ¾Ý¡£

  • ׯÏйÙÍøPDXԭλģÐ͵ÄÓ¦ÓÃ

    1. Ò©ÀíҩЧÑо¿
    ͨ¹ýPDXÄ£ÐÍ £¬×¯ÏйÙÍø¿ÉÌṩÖÖÖÖÒ©Î°üÀ¨ADC¡¢¿¹Ì塢ϸ°ûÁÆ·¨¡¢PROTAC¡¢·Ö×Ó½ºµÈ£©µÄÒ©ÀíҩЧÆÀ¼ÛЧÀÍ

    2. ·Ö×ÓˮƽµÄ»ùÒò·ÖÐÍ
    ½áºÏ¸ßͨÁ¿²âÐò£¨NGS£©¡¢µ¥Ï¸°û²âÐòµÈÇ°Ñؼ¼Êõ £¬×¯ÏйÙÍø¶ÔPDXÄ£ÐͽøÐÐÈ«ÃæµÄ»ùÒò·ÖÐÍ £¬½ÒʾÖ×Áö±¬·¢µÄ·Ö×Ó»úÖÆ £¬ÖúÁ¦·¢Ã÷еÄÖ×ÁöÖÎÁưеã¡£

Relevant laboratoriesÏà¹ØʵÑéÊÒ
  • ±ù¶³ÇÐƬ
  • ²¡ÀíÊÓ²ì
  • À䶳ÇÐƬ
  • ҩЧʵÑéÊÒ
  • Á÷ʽϸ°ûÒÇ
  • ¶¯ÎïËÇÑøÊÒ
  • ²Ù×÷ÊÒ
  • RAD
  • caliper
  • FCM
  • IVIS-Lumina-III-In-Vivo-Imaging-System
  • BD-LSRFortessa
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
ÍøÕ¾µØͼ
ÓÑÇéÁ´½Ó£º×ðÁú¿­Ê±  ×ðÁú¿­Ê±ÈËÉú¾ÍÊÇÓ®  z6comÈËÉú¾ÍÊDz©  k1ÌåÓý  bwin±ØÓ®  j9¾ÅÓιú¼ÊÕæÈË  ÐÂÀû18  ÈËÉú¾ÍÊDz©¹ÙÍø  Î¬¶àÀûÑÇÀÏÆ·ÅÆvic3308  ÀûÀ´¹ú¹ú¼ÊÍøÕ¾  168ÌåÓý¹ÙÍø  ×ðÁú¿­Ê±  pgµç×Óƽ̨  ÀûÀ´¹ú¹ú¼ÊÍøÕ¾µØÖ·  ¿­Ê±AG